MBRX Moleculin Biotech, Inc. - Common Stock
$0.61
价格 · 八月 25, 2026
截至...的财报数据 八月 13, 2026
MBRX 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$0.61
市值
—
P/E (TTM)
—
每股收益 (TTM)
—
营收 (TTM)
$0
股息收益率
—
ROE
—
负债/权益
—
52周区间
$0 – $13
MBRX 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$0
2016-12-31
→
2025-12-31
EPS
—
自由现金流
—
2016-12-31
→
2022-12-31
利润率
—
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
MBRX
同行中位数
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
MBRX
同行中位数
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
MBRX
同行中位数
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
MBRX
同行中位数
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
MBRX
同行中位数
MBRX 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
9 位分析师
- 强烈买入 2 22.2%
- 买入 6 66.7%
- 持有 1 11.1%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
3 位分析师 · 2026-08-25
中位数
$22.00
平均值
$18.33
← 低于所有目标
$0.61
最低
$2.00
最高
$31.00
中位数目标
$22.00
+3506.6%
平均目标
$18.33
+2905.5%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
3.8%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年3月31日 | $-3.54 | $-1.70 | -1.8% |
| 2025年12月31日 | $13.04 | $-6.24 | 19.3% |
| 2025年9月30日 | $-17.00 | $-4.97 | -12.0% |
| 2025年6月30日 | $-12.25 | $-9.26 | -3.0% |
| 2025年3月31日 | $-17.25 | $-14.15 | -3.1% |
| 2024年12月31日 | $-9.32 | $-32.72 | 23.4% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| MBRX | — | — | — | — | — | — |
| SNTI | — | -0.4 | -40.2% | — | — | — |
| INAB | $23M | -0.5 | — | — | -90.8% | — |
| PDSB | — | -1.0 | — | — | — | — |
| XCUR | $35M | -6.9 | — | — | -77.3% | — |
| LNAI | $513M | -2.7 | — | — | -586.4% | — |
| OSRH | — | — | — | — | — | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 13
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $16M | $18M | $19M | $19M | $14M | $13M | $11M | $10M | $5M | $1M | |
| SG&A Expense | $9M | $9M | $10M | $12M | $8M | $7M | $6M | $5M | $4M | $2M | |
| Operating Expenses | $25M | $27M | $30M | $31M | $23M | $20M | $18M | $15M | $9M | $4M | |
| Operating Income | $-25M | $-27M | $-30M | $-31M | $-23M | $-20M | $-18M | $-15M | $-9M | $-4M | |
| Interest Expense | · | · | · | · | · | · | · | · | $0 | $43.0K | |
| Other Non-op | $-20.0K | $43.0K | $48.0K | $40.0K | $40.0K | $28.0K | $15.0K | $-40.0K | $9.0K | · | |
| Pretax Income | $-34M | $-26M | · | · | · | $-17M | $-13M | · | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $-229.0K | $0 | $0 | $0 | |
| Net Income | $-34M | $-26M | $-30M | $-29M | $-16M | $-17M | $-13M | $-12M | $-10M | $-4M | |
| EPS (Basic) | $-28.42 | $-189.14 | $-15.07 | $-15.22 | $-0.59 | · | · | · | · | · | |
| Shares (Basic) | 1,184,569 | 137,720 | 1,975,610 | 1,906,960 | 26,875,927 | · | · | · | · | · | |
| EBITDA | · | · | · | $-31M | $-23M | $-20M | $-17M | $-15M | $-9M | $-4M |
资产负债表 21
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9M | $4M | $24M | $43M | $71M | $15M | $11M | $7M | $8M | $5M | |
| Receivables | · | · | · | · | · | · | $1.0K | $56.0K | · | · | |
| Prepaid Expense | $808.0K | $916.0K | $3M | $2M | $2M | $2M | $3M | $840.0K | $588.0K | $215.0K | |
| Other Current Assets | · | · | · | · | · | · | $529.0K | · | · | · | |
| Current Assets | $10M | $5M | $26M | $46M | $72M | $17M | $13M | $8M | $8M | $5M | |
| PP&E (Net) | $78.0K | $159.0K | $272.0K | $275.0K | $338.0K | $483.0K | $316.0K | $463.0K | $33.0K | $23.0K | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | $57.0K | · | |
| Accum. Depreciation | $1M | $1M | $896.0K | $769.0K | · | $474.0K | $284.0K | $93.0K | $21.0K | $6.0K | |
| Other Non-current Assets | $900.0K | $0 | · | · | · | · | · | · | · | · | |
| Total Assets | $22M | $17M | $38M | $57M | $84M | $29M | $25M | $20M | $19M | $16M | |
| Accounts Payable | $4M | $2M | $2M | $2M | $1M | $1M | $2M | $1M | $810.0K | $399.0K | |
| Accrued Liabilities | $3M | $3M | $4M | $3M | $2M | $2M | $1M | $2M | $902.0K | $650.0K | |
| Current Liabilities | $7M | $5M | $7M | $5M | $4M | $3M | $4M | $4M | $2M | $1M | |
| Capital Leases | $222.0K | $358.0K | $474.0K | $335.0K | $63.0K | $159.0K | $276.0K | · | · | · | |
| Total Liabilities | $7M | $6M | $12M | $5M | $5M | $11M | $10M | $5M | $2M | $1M | |
| Common Stock | $3.0K | $0 | $33.0K | $29.0K | $29.0K | $69.0K | $46.0K | $29.0K | $21.0K | $12.0K | |
| Retained Earnings | $-206M | $-172M | $-132M | $-102M | $-73M | $-57M | $-40M | $-26M | $-14M | $-5M | |
| AOCI | $10.0K | $-41.0K | · | · | · | · | · | · | $0 | · | |
| Stockholders' Equity | $15M | $11M | $31M | $52M | $79M | $18M | $16M | $14M | $17M | $15M | |
| Liabilities + Equity | $22M | $17M | $38M | $57M | $84M | $29M | $25M | $20M | $19M | $16M | |
| Shares Outstanding | 3,199,228 | 135,155 | 2,227,516 | 1,908,523 | 28,578,338 | 11,536,720 | 7,621,338 | 28,528,663 | 21,469,109 | 12,164,852 |
现金流 13
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $90.0K | $126.0K | $127.0K | $130.0K | $164.0K | $200.0K | $199.0K | $68.0K | $18.0K | $6.0K | |
| Stock-based Comp | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $707.0K | $324.0K | |
| Deferred Tax | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Other Non-cash | · | · | · | $-1M | $-6M | $-2M | $-6M | $-2M | $2M | $-168.7K | |
| Operating Cash Flow | $-23M | $-24M | $-24M | $-28M | $-19M | $-18M | $-17M | $-12M | $-7M | $-4M | |
| CapEx | $0 | $13.0K | $124.0K | $67.0K | $19.0K | $376.0K | $52.0K | $417.0K | $28.0K | $21.0K | |
| Investing Cash Flow | $0 | $-13.0K | $-124.0K | $-67.0K | $-19.0K | $-374.0K | $-51.0K | $-417.0K | $-28.0K | $-121.0K | |
| Stock Issued | · | · | · | $0 | $75M | $23M | $19M | · | · | · | |
| Net Stock Activity | · | · | · | $0 | $75M | $23M | · | · | · | · | |
| Financing Cash Flow | $27M | $5M | $4M | $-23.0K | $75M | $23M | $21M | $12M | $10M | $9M | |
| Net Change in Cash | $5M | $-19M | $-20M | $-28M | $56M | $4M | $4M | $-580.0K | $3M | $5M | |
| Taxes Paid | $0 | $0 | · | · | $15.0K | $24.0K | $19.0K | $21.0K | $0 | $0 | |
| Free Cash Flow | · | · | · | $-28M | $-19M | $-18M | $-17M | $-13M | $-7M | $-4M |
盈利能力 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | · | · | · | -41.0% | -28.1% | -64.0% | -58.9% | -60.8% | -54.7% | -47.8% | |
| ROE | · | · | · | -52.5% | -19.8% | -107.7% | -76.4% | -81.2% | -61.1% | -55.2% | |
| ROIC | · | · | · | · | · | -111.2% | · | · | · | · |
流动性与偿付能力 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | · | 9.5 | 20.0 | 5.9 | 3.8 | 2.1 | 3.7 | 3.9 | |
| Quick Ratio | · | · | · | 9.0 | 19.6 | 5.2 | 3.0 | 1.8 | 3.5 | 3.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -89.9 |
效率 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | 0.0 | · | · | · |
估值 (TTM) 7
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-34M | $-26M | $-30M | $-29M | $-16M | $-17M | $-13M | $-12M | $-10M | $-4M | |
| Market Cap | · | · | · | · | $797M | $828M | $3.77B | $2.67B | $3.59B | $2.50B | |
| P/B | · | · | · | · | 10.1 | 46.6 | 241.8 | 187.1 | 210.0 | 166.9 | |
| P / Tangible Book | 0.7 | 0.5 | 0.9 | · | 10.1 | 46.6 | · | · | · | · | |
| P / Cash Flow | · | · | · | · | -42.1 | -46.6 | -219.0 | -218.8 | -490.7 | -663.0 | |
| P / FCF | · | · | · | · | -42.0 | -45.6 | -218.3 | -211.6 | -488.8 | -659.3 |
损益表 11
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $5M | $5M | $5M | $4M | $4M | $3M | $4M | $5M | $4M | $4M | $7M | $3M | $4M | $6M | $4M | $6M | |
| SG&A Expense | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $3M | $3M | $3M | |
| Operating Expenses | $8M | $8M | $8M | $6M | $6M | $6M | $7M | $7M | $6M | $7M | $9M | $6M | $6M | $8M | $7M | $9M | |
| Operating Income | $-8M | $-8M | $-8M | $-6M | $-6M | $-6M | $-7M | $-7M | $-6M | $-7M | $-9M | $-6M | $-6M | $-8M | $-7M | $-9M | |
| Other Non-op | $13.0K | $76.0K | $-49.0K | $16.0K | $4.0K | $9.0K | $12.0K | $9.0K | $11.0K | $11.0K | $18.0K | $13.0K | $9.0K | $8.0K | $1.0K | $19.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-8M | $-13M | $16M | $-25M | $-18M | $-6M | $-7M | $-7M | $-6M | $-6M | $-10M | $-6M | $-6M | $-8M | $-7M | $-9M | |
| EPS (Basic) | $-1.40 | $-3.54 | $-25.96 | $-0.68 | $-28.68 | $-15.80 | $-182.27 | $-1.89 | $-2.37 | $-2.61 | $-5.10 | $-2.82 | $-3.02 | $-4.13 | $-14.44 | $-0.30 | |
| Shares (Basic) | 5,680,717 | 4,124,482 | -60,990,058 | 37,304,455 | 621,056 | 373,751 | -8,585,976 | 3,714,278 | 2,543,244 | 2,466,174 | -3,907,596 | 1,987,283 | 1,979,258 | 1,916,665 | -83,882,002 | 28,627,610 | |
| EBITDA | $-8M | $-8M | · | $-6M | $-6M | $-6M | · | $-7M | $-6M | $-7M | · | $-6M | $-6M | $-8M | · | $-9M |
资产负债表 18
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7M | $10M | $9M | $7M | $8M | $8M | $4M | $9M | $11M | $17M | $24M | $25M | $32M | $37M | $43M | $50M | |
| Prepaid Expense | $1M | $644.0K | $808.0K | $1M | $2M | $2M | $916.0K | $2M | $3M | $2M | $3M | $3M | $3M | $2M | $2M | $3M | |
| Current Assets | $9M | $11M | $10M | $8M | $9M | $9M | $5M | $12M | $14M | $19M | $26M | $28M | $35M | $39M | $46M | $53M | |
| PP&E (Net) | $62.0K | $70.0K | $78.0K | $77.0K | $99.0K | $127.0K | $159.0K | $190.0K | $221.0K | $240.0K | $272.0K | $225.0K | $229.0K | $244.0K | $275.0K | $306.0K | |
| Accum. Depreciation | · | · | $1M | · | · | · | $1M | · | · | · | $896.0K | · | · | · | $769.0K | · | |
| Other Non-current Assets | $900.0K | $900.0K | $900.0K | $900.0K | $900.0K | · | $0 | · | · | · | · | · | · | · | · | · | |
| Total Assets | $21M | $23M | $22M | $20M | $22M | $21M | $17M | $23M | $26M | $31M | $38M | $40M | $47M | $51M | $57M | $65M | |
| Accounts Payable | $4M | $5M | $4M | $2M | $4M | $3M | $2M | $3M | $3M | $2M | $2M | $2M | $4M | $2M | $2M | $4M | |
| Accrued Liabilities | $5M | $3M | $3M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $4M | $2M | $2M | $3M | $3M | $3M | |
| Current Liabilities | $9M | $8M | $7M | $6M | $8M | $7M | $5M | $6M | $6M | $5M | $7M | $4M | $7M | $5M | $5M | $6M | |
| Capital Leases | $147.0K | $185.0K | $222.0K | $258.0K | $292.0K | $326.0K | $358.0K | $390.0K | $420.0K | $450.0K | $474.0K | $496.0K | $291.0K | $308.0K | $335.0K | $365.0K | |
| Total Liabilities | $10M | $8M | $7M | $47M | $29M | $21M | $6M | $16M | $8M | $9M | $12M | $4M | $7M | $5M | $5M | $7M | |
| Common Stock | $7.0K | $5.0K | $3.0K | $49.0K | $30.0K | $14.0K | $0 | $3.0K | $3.0K | $2.0K | $33.0K | $30.0K | $30.0K | $30.0K | $29.0K | $29.0K | |
| Retained Earnings | $-226M | $-219M | $-206M | $-222M | $-167M | $-160M | $-172M | $-151M | $-141M | $-137M | $-132M | $-121M | $-116M | $-110M | $-102M | $-95M | |
| AOCI | $-64.0K | $-52.0K | $10.0K | · | · | · | $-41.0K | · | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $12M | $15M | $15M | $-27M | $-7M | $42.0K | $11M | $7M | $18M | $22M | $26M | $35M | $40M | $46M | $52M | $58M | |
| Liabilities + Equity | $21M | $23M | $22M | $20M | $22M | $21M | $17M | $23M | $26M | $31M | $38M | $40M | $47M | $51M | $57M | $65M | |
| Shares Outstanding | 7,100,000 | 5,336,350 | 3,199,228 | 49,498,576 | 30,207,494 | 14,127,494 | 135,155 | 3,001,895 | 2,560,785 | 2,311,536 | 2,227,516 | 29,810,443 | 29,789,322 | 29,600,323 | 1,908,523 | 28,627,827 |
现金流 11
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $8.0K | $8.0K | $9.0K | $21.0K | $29.0K | $31.0K | $32.0K | $31.0K | $31.0K | $32.0K | $34.0K | $32.0K | $31.0K | $30.0K | $32.0K | $32.0K | |
| Stock-based Comp | $436.0K | $380.0K | $459.0K | $303.0K | $417.0K | $485.0K | $427.0K | $353.0K | $453.0K | $493.0K | $479.0K | $493.0K | $513.0K | $499.0K | $535.0K | $699.0K | |
| Other Non-cash | · | $6M | · | · | · | $1M | · | · | · | $-2M | · | · | · | $1M | · | · | |
| Operating Cash Flow | $-7M | $-6M | $-5M | $-7M | $-6M | $-5M | $-5M | $-6M | $-6M | $-7M | $-5M | $-8M | $-5M | $-6M | $-7M | $-8M | |
| CapEx | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $13.0K | $0 | $81.0K | $28.0K | $15.0K | $0 | $0 | $0 | |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-13.0K | $0 | $-81.0K | $-28.0K | $-15.0K | $0 | $0 | $0 | |
| Stock Issued | · | · | · | · | · | · | · | · | $0 | $0 | · | $0 | $70.0K | $141.0K | · | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $141.0K | · | · | |
| Financing Cash Flow | $4M | $8M | $7M | $6M | $5M | $8M | $1.0K | $5M | $-25.0K | $0 | $4M | $-4.0K | $49.0K | $141.0K | $0 | $-11.0K | |
| Net Change in Cash | $-3M | $1M | $2M | $-854.0K | $-159.0K | $3M | $-5M | $-1M | $-6M | $-7M | $-1M | $-8M | $-5M | $-6M | $-7M | $-8M | |
| Free Cash Flow | · | · | · | · | · | $-5M | · | · | · | · | · | · | · | $-6M | · | · |
盈利能力 2
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -35.8% | -57.9% | · | -116.1% | -32.4% | -24.8% | · | -33.7% | -11.9% | -12.1% | · | -10.7% | -9.9% | -12.2% | · | -11.2% | |
| ROE | -345.3% | -168.7% | · | 261.3% | -145.0% | -59.5% | · | -49.7% | -14.9% | -14.8% | · | -12.0% | -11.2% | -13.4% | · | -12.3% |
流动性与偿付能力 2
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 1.4 | · | 1.4 | 1.1 | 1.4 | · | 2.1 | 2.4 | 3.5 | · | 7.1 | 5.4 | 7.8 | · | 8.4 | |
| Quick Ratio | 0.8 | 1.3 | · | 1.2 | 1.0 | 1.1 | · | 1.7 | 1.9 | 3.1 | · | 6.3 | 4.9 | 7.4 | · | 7.9 |
效率 1
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
估值 (TTM) 7
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| Net Income TTM | $-64M | $-62M | · | $-56M | $-37M | $-25M | · | $-25M | $-24M | $-26M | · | $-28M | $-29M | $-30M | · | $-27M | |
| Market Cap | $20M | $12M | · | $26M | $9M | $14M | · | $9M | $9M | $14M | · | $191M | $259M | $426M | · | $455M | |
| P/B | 1.7 | 0.8 | · | -1.0 | -1.3 | 327.6 | · | 1.1 | 0.5 | 0.6 | · | 5.4 | 6.4 | 9.3 | · | 7.8 | |
| P / Tangible Book | 1.7 | 0.8 | · | · | · | 327.6 | · | 1.1 | 0.5 | 0.6 | · | 5.4 | 6.4 | 9.3 | · | 7.8 | |
| P / Cash Flow | · | -2.0 | · | · | · | -3.0 | · | · | · | -2.0 | · | · | · | -70.8 | · | · | |
| P / FCF | · | · | · | · | · | -3.0 | · | · | · | · | · | · | · | -70.8 | · | · |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $0 | $0 | $0 | $0 | $0 |
| 净收入 | $-34M | $-26M | $-30M | $-29M | $-16M |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 流动比率 | — | — | — | 9.5 | 20.0 |
| 速动比率 | — | — | — | 9.0 | 19.6 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | — | — | — | $-28M | $-19M |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 20 家申报者 · $441K 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 5 (-2 与上一季度对比) | 7 (+4 与上一季度对比) | 6 (+1 与上一季度对比) | 0 (-1 与上一季度对比) | +12K |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $117780 | 42215 | 26.73% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $114057 | 40881 | 25.88% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $83374 | 29883 | 18.92% | 股份 |
| XTX Topco Ltd | $64008 | 22942 | 14.53% | 股份 |
| Rockefeller Capital Management L.P. | $41850 | 15000 | 9.50% | 股份 |
| CITIGROUP INC | $7460 | 2674 | 1.69% | 股份 |
| Tower Research Capital LLC (TRC) | $5379 | 1928 | 1.22% | 股份 |
| BARCLAYS PLC | $1733 | 621 | 0.39% | 股份 |
| BlackRock, Inc. | $1370 | 491 | 0.31% | 股份 |
| EFG International AG | $1211 | 434 | 0.27% | 股份 |
| JONES FINANCIAL COMPANIES LLLP | $1177 | 360 | 0.27% | 股份 |
| WELLS FARGO & COMPANY/MN | $558 | 200 | 0.13% | 股份 |
| NFSG Corp | $318 | 114 | 0.07% | 股份 |
| SBI Securities Co., Ltd. | $123 | 44 | 0.03% | 股份 |
| Sandy Spring Bank | $87 | 89 | 0.02% | 股份 |
| VANGUARD GROUP INC | $79 | 24 | 0.02% | 股份 |
| MORGAN STANLEY | $56 | 20 | 0.01% | 股份 |
| DANSKE BANK A/S | $6 | 2 | 0.00% | 股份 |
| CVA Family Office, LLC | $3 | 1 | 0.00% | 股份 |
| OSAIC HOLDINGS, INC. | $2 | 1 | 0.00% | 股份 |
公司内部人士 10 位内幕人士 · 3 位高管 · 7 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Walter V Klemp | CEO and President | 2026年8月3日 A | 564340 | 0 | 0 | $0 |
| Jonathan P. Foster | Chief Financial Officer | 2026年8月3日 P | 305673 | 0 | 0 | $0 |
| Donald H Picker | Chief Science Officer | 2026年8月3日 P | 174086 | 0 | 0 | $0 |
| Joy Yan | 董事 | 2025年11月12日 A | — | 0 | 0 | $0 |
| Robert E. George | 董事 | 2025年11月12日 A | 14660 | 0 | 0 | $0 |
| John M Climaco | 董事 | 2025年11月12日 A | — | 0 | 0 | $0 |
| Elizabeth Cermak | 董事 | 2025年11月12日 A | — | 0 | 0 | $0 |
| Michael D Cannon | 董事 | 2025年11月12日 A | — | 0 | 0 | $0 |
| Jacqueline Northcut | 董事 | 2017年5月5日 P | 1000 | 0 | 0 | $0 |
| Waldemar Priebe | 10% 所有者 | 2017年8月16日 S | 2781573 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 1 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0.00% | 42215 SH | 2026年8月19日 | 每日 |